In situ localization of CD83-positive dendritic cells in psoriatic lesions

被引:23
作者
Koga, T [1 ]
Duan, H [1 ]
Urabe, K [1 ]
Furue, M [1 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Dermatol, Higashi Ku, Fukuoka 8128582, Japan
关键词
CD83; psoriasis; immunohistochemistry; dendritic cells; antigen-presenting cells;
D O I
10.1159/000051825
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background. Dendritic cells (DC) are considered to be the most potent antigen-p resenting cells, and CD83 is expressed at a high level on immune-competent, activated and mature DC. Although changes in the number or localization of mature and activated CD83+ DC could be expected in psoriasis, there is little information on such changes. Aim: Morphological identification of CD83+ DC in psoriatic skin lesions. Materials and Methods: Immunohistochemical staining was performed in 5 specimens of psoriasis vulgaris and 6 specimens of pustular psoriasis. Formalin-fixed, paraffin-em bedded sections were used for examination in this study. The skin sections were pretreated with 0.1% trypsin for 60 min at 37degreesC prior to immunostaining for CD83. Results: A small but significant subpopulation of CD83+ DC was found in the upper dermis. In addition, CD83+ DC were occasionally scattered in the epidermis. The most common distribution pattern of CD83+ DC was as clusters with mononuclear lymphoid cells in the upper dermis. CD83+ DC were in close contact with lymphocytes. High-intensity staining of CD83 antigens was detected not only on the surface, but also in the cytoplasm of DC. Conclusion: These results indicate that activated and mature CD83+ DC may play a role in the immune response in psoriasis and provide in vivo support for the concept that CD83+ DC provide signals for direct intralesional T cell activation. Copyright (C) 2002 S. Karger AG. Basel.
引用
收藏
页码:100 / 103
页数:4
相关论文
共 14 条
[1]   Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells [J].
Abrams, JR ;
Kelley, SL ;
Hayes, E ;
Kikuchi, T ;
Brown, MJ ;
Kang, SW ;
Lebwohl, MG ;
Guzzo, CA ;
Jegasothy, BV ;
Linsley, PS ;
Krueger, JG .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (05) :681-693
[2]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[3]  
Berti E, 1998, EUR J DERMATOL, V8, P421
[4]   The pathogenesis of psoriasis: Immunological facts and speculations [J].
Bos, JD ;
De Rie, MA .
IMMUNOLOGY TODAY, 1999, 20 (01) :40-46
[5]   Nonlymphoid intraepidermal mononuclear cell collections (pseudo-Pautrier abscesses) - A morphologic and immunophenotypical characterization [J].
Candiago, E ;
Marocolo, D ;
Manganoni, MA ;
Leali, C ;
Facchetti, F .
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2000, 22 (01) :1-6
[6]   Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites [J].
Dieu, MC ;
Vanbervliet, B ;
Vicari, A ;
Bridon, JM ;
Oldham, E ;
Aït-Yahia, S ;
Brière, F ;
Zlotnik, A ;
Lebecque, S ;
Caux, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (02) :373-386
[7]   Dendritic cells: Unique leukocyte populations which control the primary immune response [J].
Hart, DNJ .
BLOOD, 1997, 90 (09) :3245-3287
[8]   Immunological activation of dermal Langerhans cells in contact with lymphocytes in a model of human inflamed skin [J].
Katou, F ;
Ohtani, H ;
Saaristo, A ;
Nagura, H ;
Motegi, K .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (02) :519-527
[9]   GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR PROMOTES DIFFERENTIATION AND SURVIVAL OF HUMAN PERIPHERAL-BLOOD DENDRITIC CELLS-INVITRO [J].
MARKOWICZ, S ;
ENGLEMAN, EG .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (03) :955-961
[10]   Dermal dendritic cells associated with T lymphocytes in normal human skin display an activated phenotype [J].
McLellan, AD ;
Heiser, AE ;
Sorg, RV ;
Fearnley, DB ;
Hart, DNJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 111 (05) :841-849